ALRN - Aileron Therapeutics misses by $0.03 May, 08 2019 05:02 PM Aileron Therapeutics Inc. Aileron Therapeutics (NASDAQ:ALRN): Q1 GAAP EPS of -$0.49 misses by $0.03.More news on: Aileron Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...